TrialThe American journal of psychiatry2022

Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial.

Carlos M Grilo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.